MPS Powered by Eureka

Current Nanomedicine

ISSN: 2468-1873 (Print)
eISSN: 2468-1881 (Online)

Scopus
CiteScore:

2

Aims and Scope:Current Nanomedicine publishes full-length/mini reviews, research articles and guest edited thematic issues in the field of nanomedicine. The journal is essential reading for all academic, industrial and clinical researchers who wish to be kept informed about important breakthroughs in nanomedicine.

Editor-in-Chief:


Victor M. Castano Center of Applied Physics and Advanced Technology
National Autonomous University of Mexico
Santiago de Querétaro
Mexico

Indexed in:


Scopus, Cabell's Directory/Journalytics... View all

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2025
Nanomaterials for Drug Delivery System in Chronic and Infectious Disease Therapy

The exploration of nanomaterials for drug delivery systems represents a cutting-edge frontier in modern medical research. In our tThematic Iissue, we delve into the extensive scope of utilizing nanotechnology to combat chronic and infectious diseases. This emerging field holds tremendous promise, offering innovative solutions to longstanding challenges in healthcare. At its core, the significance of this topic lies in the potential to revolutionize drug delivery mechanisms. Nanomaterials, with their unique properties and tunable characteristics, provide... see more

Submission closes on: Dec 31, 2025
Cutting-Edge Nanomedicine Approaches in Oncology: Bottlenecks and Breakthroughs

Cancer is a terrifying disease that ranks among the most pressing health concerns facing humanity and necessitates a proactive approach to treatment. Nanomedicine, a rapidly evolving field at the intersection of nanotechnology and medicine, holds immense promise in revolutionizing cancer treatment. By leveraging nanoscale materials and devices, researchers are developing novel approaches to diagnose, treat, and monitor cancer with unprecedented precision. However, despite remarkable advancements, several challenges, or bottlenecks, persist in translating these innovations from... see more